The Josep Carreras Institute against Leukaemia has dismissed six workers who alerted the Anti-Fraud Office about the possible misappropriation of public funds. The amounts in question are 400,000 euros and 781,000 euros from a state program. The affected individuals, who have legal protection as whistleblowers, have filed labor lawsuits for retaliation. The first trial is scheduled for July 2026, and the rest for 2027.
How the lack of transparency affects oncology research 🔍
In a sector where funding is key, any misappropriation of public resources directly impacts the development of new therapies. Internal control and audit systems are basic tools to prevent these situations. Without effective transparency mechanisms, money intended for research projects can end up in unjustified items, delaying necessary advances for patients and clinical trials.
The Carreras method: first fire, then investigate if there was a reason 😅
It seems the Institute has applied the advanced management protocol: if someone discovers a financial hole, you plug it by firing the person who found it. That way, science advances, but backwards. While the trials arrive in 2026, the missing 400,000 euros are surely funding some secret study on how to make evidence disappear without a trace.